The abstract, "A DOSE ESCALATION STUDY OF SAFETY & PK OF TMB-365 & TMB-380 IN SUPPRESSED HIV-INFECTED INDIVIDUALS", has been accepted by CROI 2024

TaiMed Biologics is a commercial-stage CD4-targeted biologics company advancing antibody-based therapies for long-acting HIV treatment and broader immune-directed innovation.
About | Our Science | Pipeline & Products | CDMO | Partners | News | Investors

TaiMed HQ

TEL：02-26580058
TIME：8:00AM-18:00PM
E-mail：ir@taimedbio.com
ADD：3F.,NO.607,Ruiguang Rd.,Neihu Dist.,Taipei City 11492,Taiwan(R.O.C.)

Hsinchu Branch Office

TEL：03-6212355
TIME：8:00AM-18:00PM
ADD：No. 18, Ln. 15, Shengyi 5th Rd., Zhubei City, Hsinchu County, Taiwan (R.O.C.)
Contact CDMO Service

Corporate General Inquiries Privacy Business Development Partnerships Investor Relations CDMO Services

TaiMed / Taimedbiologics / Clinical Development of Anti-HIV Medications / Trogarzo® / TaiMed biologics cdmo / cdmo services / HIV / cGMP Facility

256 bit SSL Encryption

Recommend using Chrome, Firefox, Safari latest version of the browser.

Designed by MIRACLEWeb Design

Contact CDMO Service